Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1078.532 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.532/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.532 |
Version | 20230720 |
Status | active |
Date | 2023-07-20T01:01:20-04:00 |
Name | IL5Antagonists |
Title | IL5 Antagonists |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: Medications that include IL-5 antagonists for asthma),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC:),(Inclusion Criteria: RxCUIs for prescribable drugs which include IL-5 antagonist ingredients (mepolizumab, reslizumab)),(Exclusion Criteria: Non-prescribable RxCUIs) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
No narrative content found in resource
{ "resourceType": "ValueSet", "id": "2.16.840.1.113762.1.4.1078.532", "meta": { "versionId": "6", "lastUpdated": "2023-12-21T17:43:03.000-05:00", "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ] }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueContactDetail": { "name": "Optum Author" } }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2023-07-20" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2023-07-20" } ], "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.532", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113762.1.4.1078.532" } ], "version": "20230720", "name": "IL5Antagonists", "title": "IL5 Antagonists", "status": "active", "date": "2023-07-20T01:01:20-04:00", "publisher": "Optum Steward", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "US" } ] } ], "purpose": "(Clinical Focus: Medications that include IL-5 antagonists for asthma),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC:),(Inclusion Criteria: RxCUIs for prescribable drugs which include IL-5 antagonist ingredients (mepolizumab, reslizumab)),(Exclusion Criteria: Non-prescribable RxCUIs)", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "concept": [ { "code": "1720597", "display": "mepolizumab" }, { "code": "1720598", "display": "mepolizumab 100 MG" }, { "code": "1720599", "display": "mepolizumab Injectable Product" }, { "code": "1720600", "display": "mepolizumab Injection" }, { "code": "1720601", "display": "mepolizumab 100 MG Injection" }, { "code": "1720602", "display": "Nucala" }, { "code": "1720603", "display": "mepolizumab 100 MG [Nucala]" }, { "code": "1720604", "display": "mepolizumab Injection [Nucala]" }, { "code": "1720605", "display": "Nucala Injectable Product" }, { "code": "1720606", "display": "mepolizumab 100 MG Injection [Nucala]" }, { "code": "1746889", "display": "reslizumab" }, { "code": "1746890", "display": "reslizumab 10 MG/ML" }, { "code": "1746891", "display": "reslizumab Injectable Product" }, { "code": "1746892", "display": "reslizumab Injection" }, { "code": "1746893", "display": "10 ML reslizumab 10 MG/ML Injection" }, { "code": "1746894", "display": "Cinqair" }, { "code": "1746895", "display": "reslizumab 10 MG/ML [Cinqair]" }, { "code": "1746896", "display": "reslizumab Injection [Cinqair]" }, { "code": "1746897", "display": "Cinqair Injectable Product" }, { "code": "1746898", "display": "10 ML reslizumab 10 MG/ML Injection [Cinqair]" }, { "code": "2170988", "display": "mepolizumab 100 MG/ML" }, { "code": "2170989", "display": "mepolizumab Auto-Injector" }, { "code": "2170990", "display": "1 ML mepolizumab 100 MG/ML Auto-Injector" }, { "code": "2170991", "display": "mepolizumab 100 MG/ML [Nucala]" }, { "code": "2170992", "display": "mepolizumab Auto-Injector [Nucala]" }, { "code": "2170993", "display": "1 ML mepolizumab 100 MG/ML Auto-Injector [Nucala]" }, { "code": "2173819", "display": "mepolizumab Prefilled Syringe" }, { "code": "2173820", "display": "1 ML mepolizumab 100 MG/ML Prefilled Syringe" }, { "code": "2173821", "display": "mepolizumab Prefilled Syringe [Nucala]" }, { "code": "2173822", "display": "1 ML mepolizumab 100 MG/ML Prefilled Syringe [Nucala]" }, { "code": "2596444", "display": "0.4 ML mepolizumab 100 MG/ML Prefilled Syringe" }, { "code": "2596445", "display": "0.4 ML mepolizumab 100 MG/ML Prefilled Syringe [Nucala]" } ] } ] }, "expansion": { "identifier": "urn:uuid:8dbbeab7-1068-4737-8179-b0902274e635", "timestamp": "2025-05-23T17:50:37-04:00", "total": 32, "contains": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1720597", "display": "mepolizumab" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1720598", "display": "mepolizumab 100 MG" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1720599", "display": "mepolizumab Injectable Product" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1720600", "display": "mepolizumab Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1720601", "display": "mepolizumab 100 MG Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1720602", "display": "Nucala" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1720603", "display": "mepolizumab 100 MG [Nucala]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1720604", "display": "mepolizumab Injection [Nucala]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1720605", "display": "Nucala Injectable Product" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1720606", "display": "mepolizumab 100 MG Injection [Nucala]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1746889", "display": "reslizumab" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1746890", "display": "reslizumab 10 MG/ML" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1746891", "display": "reslizumab Injectable Product" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1746892", "display": "reslizumab Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1746893", "display": "10 ML reslizumab 10 MG/ML Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1746894", "display": "Cinqair" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1746895", "display": "reslizumab 10 MG/ML [Cinqair]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1746896", "display": "reslizumab Injection [Cinqair]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1746897", "display": "Cinqair Injectable Product" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1746898", "display": "10 ML reslizumab 10 MG/ML Injection [Cinqair]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2170988", "display": "mepolizumab 100 MG/ML" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2170989", "display": "mepolizumab Auto-Injector" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2170990", "display": "1 ML mepolizumab 100 MG/ML Auto-Injector" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2170991", "display": "mepolizumab 100 MG/ML [Nucala]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2170992", "display": "mepolizumab Auto-Injector [Nucala]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2170993", "display": "1 ML mepolizumab 100 MG/ML Auto-Injector [Nucala]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2173819", "display": "mepolizumab Prefilled Syringe" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2173820", "display": "1 ML mepolizumab 100 MG/ML Prefilled Syringe" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2173821", "display": "mepolizumab Prefilled Syringe [Nucala]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2173822", "display": "1 ML mepolizumab 100 MG/ML Prefilled Syringe [Nucala]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2596444", "display": "0.4 ML mepolizumab 100 MG/ML Prefilled Syringe" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2596445", "display": "0.4 ML mepolizumab 100 MG/ML Prefilled Syringe [Nucala]" } ] } }